MENU

Tahseen I. Al-Saleem, MD

Tahseen Al-Saleem, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Research Program

Treatment Philosophy

I chose to work at Fox Chase because I like oncologic (cancer) pathology and love the institutional environment. The best part of my job is interaction with other colleagues: pathologists, clinicians and researchers. That is why I've stayed at Fox Chase for more than 15 years.

Advances in medicine have improved the way in which we understand cancer and deal with it. An accurate, comprehensive diagnosis means everything to the patients who come here as well as the physicians who plan their treatment. As a pathologist, I enjoy working with the other physicians because they count on our accuracy in order to get best results in cancer management and for future progress in the field.

Education, Training & Credentials

Educational Background

    St. Christopher's Hospital for Children, Philadelphia - See more at: http://www.foxchase.org/physicians/team/pathology/al-saleem.html#sthash....
    • Fellow, St. Christopher's Hospital for Children, Philadelphia, PA
    • Resident, Pathology, Temple University Hospital, Philadelphia, PA
    • MB, ChB, Medicine, University of Baghdad School of Medicine, Iraq, 1961

    Certifications

    • American Board of Pathology
    • Anatomic and Clinical Pathology
    • Hematopathology

    Memberships

    • College of American Pathologists
    • Clinical Cytometry Society
    • American Society of Hematology

    Honors & Awards

    • Lifetime Achievement Award, Iraqi Society of United Kingdom, 2016
    • Lifetime Achievement Award: Iraqi Medical Sciences Association , 2014
    • Award of excellence in Pathology: Mandaean Medical Professionals Association 5th Convention, 2014
    • Best Medical Oncology Teacher, Fox Chase Cancer Center, 2005
    • Best Professor's Award, University of Baghdad, 1985
    Research Profile

    Research Program

    Research Interests

    • Contribution to the development of animal models for lymphoma
    • Investigation and description of new or unusual hemopoietic malignancies
    Publications

    Selected Publications

    Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T.  Lymphopenia is an Independent Predictor of inferior outcome in clear cell renal carcinoma. J. Urol. 2013 Feb; 189(2): 454-61. doi: 10.1016/j.juro.2012. 09. 166. Epub 2012 Oct 4. PubMed

    Post-radiotherapy prostate biopsies reveal heightened apex positive relative to other prostate regions sampled. Huang KT, Stoyanova R, Waler G, Sandler K, Studenski MT, Dogan N. Al-Saleem T,Buyyounouski MD, Horwotz EM, Pollack A. Radiother Onncol. 2015 Apr:115(1):101-6 doi: 10.1016/j.radonc.2015.03.006. Epub 2015 May 8. PubMed

    PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection. Alexander W. MacFarlane IV1, Mowafaq Jillab14, Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Samuel Litwin, Essel Dulaimi, Tahseen Al-Saleem, and Kerry S. Campbell PubMed

    MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec PubMed

    Renal cell carcinoma metastasis to a contralateral oncocytoma in a patient presenting with bilateral synchronous renal tumors. Mehrazin R, Wong YN, Wu H, Al-Saleem T, Smaldone M. Clin Genitourin Cancer. 2013 Dec;11(4):e27-9. doi: 10.1016/j.clgc.2013.06.001. Epub 2013 Sep

    A. J Urol. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass:   implications for  treating patients following renal biopsy. Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov 2014 Feb;191(2):296-300. doi: 10.1016/j.juro.2013.07.059. Epub 2013 Jul 27. PubMed

    Gleason scoring at a comprehensive cancer center: what's the difference? Townsend NC, Ruth K, Al-Saleem T, Horwitz EM, Sobczak M, Uzzo RG, Viterbo R, Buyyounouski MK. PubMed

    Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice. Kadariya Y, Tang B, Wang L, Al-Saleem T, Hayakawa K, Slifker MJ, Kruger WD. PLoS One. 2013 Jun 26;8(6):e67635. Print 2013. PubMed

    Is there a benefit to frozen section analysis at the time of partial nephrectomy? Sterious SN, Simhan J, Smaldone MC, Tsai KJ, Canter D, Wameedh E, Li T, Helstrom J, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Al-Saleem T, Uzzo RG. Can J Urol. 2013 Jun;20(3):6778-84. PubMed

    Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Mehrazin R, et al. Urol Oncol. 2015. PubMed

    Gleason Scoring, Updates of the Updates Journal of cancer prevention and research, Editorial , May 2016 

    Low Level of Blood CD4+ T Cells Is an Independent Predictor of Inferior Progression-free   Survival in Diffuse Large B-cell Lymphoma. Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):83-88. doi: 10.1016/j.clml.2016.11.005. Epub 2016 Nov 30. PubMed

    What Is “Cancer” Is There A Need for New Terminologies? Journal of Cancer Prevention and Current Research. Vol 4 Issue 2 2016